AzTrials
AzTrials

Nursing CariesNCT05228366

Heel Warming With Mild and Hot Thermofor Applied Before Heel Lance

A study testing Heel warming with mild thermofor group, Heel warming with hot thermofor group and Ineffective heel warming with thermofor group in people with Nursing Caries, run by Isparta University of Applied Sciences at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Heel warming with thermophor during heel blood collection is a cost-effective and easy-to-apply method. In previous studies, it has been shown that applying heat to the heel reduces the pain of taking heel blood, increases comfort and shortens the procedure time and total crying time. Read more about this study

Who is it for?
Ages 24 to 72 hoursHealthy volunteers can take part
Conditions the study is for
Nursing Caries
What is being tested?
Heel warming with mild thermofor group, Heel warming with hot thermofor group and Ineffective heel warming with thermofor group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteTurkey (Türkiye)
Study dates
11 May 2022to 18 Oct 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 24 to 72 hours
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Born between 38-42 gestational weeks (term newborns)
  • Newborns with a birth weight of 2500-4400 grams
  • Newborns with stable physiological parameters and general condition
  • Newborns with vitamin K and hepatitis B vaccine in the delivery room
  • Newborns with eight or more Apgar scores in the first and fifth minutes

Who cannot join

  • Newborns with problems during pregnancy, labor and postpartum
  • Newborns with congenital anomaly
  • Newborns receiving pharmacological or non-pharmacological pain management intervention before the procedure
  • Newborns with receiving oxygen therapy
  • Newborns with having undergone a surgical procedure
  • Newborns with sepsis or suspected sepsis
  • Newborns whose parents state that they want to leave the study while the study continues

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Isparta University of Applied Sciences

    Isparta, 32100

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Heel Warming With Mild and Hot Thermofor Applied Before Heel Lance on Total Crying Time and Procedure Time in Healthy Term Newborns.: A Randomized Clinical Trial

Heel warming with thermophor during heel blood collection is a cost-effective and easy-to-apply method. In previous studies, it has been shown that applying heat to the heel reduces the pain of taking heel blood, increases comfort and shortens the procedure time and total crying time. Warm aplication increases the skin surface temperature, causing proximal vasodilation, thereby accelerating blood flow and increasing blood circulation. Increased blood circulation can reduce the pressure applied to the heel of newborns, shorten the procedure time, reduce the perception of pain and increase comfort. As a result of the literature review, it is seen that there is no clarity about the temperature degrees used in heel heating. It has been seen in the literature that warming the heel before heel blood collection is often carried out as mild (34-37C) or hot (38-40C). This study aims to determine heel warming with mild (34-37C) and hot (38-40C) thermofor applied before heel lance on total crying time and procedure time in healthy term newborns.

Read the detailed description

Aim: The effect of heel warming with mild (34-37C) and hot (38-40C) thermofor applied before capillary heel blood sampling on total crying time and procedure time in term newborns.

Method: This study was planned as a randomized controlled, experimental, double-blind, single-center study. The universe of the research will be term newborns whose heel blood samples will be taken within the scope of the Newborn Screening Program (NSP) in the Isparta Şehir Hospital Gynecology and Obstetrics III Service.

The sample of the study was determined as 120 healthy term newborn (40 control, 40 intervention 1, 40 intervention 2).

Intervention: In this study, ineffective heel warming with thermofor will be applied to the control group; heel warming with mild (34-37C) thermofor will be applied to the intervention group 1; heel warming with hot (38-40C) thermofor will be applied to the intervention group 2. All newborns will breastfed from their mothers during and after the procedure.

Data collection instruments: Newborn Information Form (NIF).

Data collection: Heel blood collection will be video-recorded from the pre-evaluation stage (one minute before the intervention) until the 5th minute after the puncture heel. The video recording will be monitored by independent evaluator who do not know the purpose of the study, and the processing time will be recorded.

Conditions
Nursing Caries
Being tested
Heel warming with mild thermofor group, Heel warming with hot thermofor group, Ineffective heel warming with thermofor group
Keywords
Heel warming, Heel Lance, Newborn, Total crying time, Processing time

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Heel warming with mild thermofor groupOther

    Heel warming will be applied to the newborns in the ıntervention group 1 with a thermofor containing 34-37C warm water for 5 minutes before the heel blood collection procedure. During the procedure, the general condition of the newborn and the changes in his skin will be observed closely. Heel blood collection will be performed by following the standard procedure steps that are routinely applied in the service

  • Heel warming with hot thermofor groupOther

    Heel warming will be applied to the newborns in the ıntervention group 2 with a thermofor containing 38-40C warm water for 5 minutes before the heel blood collection procedure. During the procedure, the general condition of the newborn and the changes in his skin will be observed closely. Heel blood collection will be performed by following the standard procedure steps that are routinely applied in the service

  • Ineffective heel warming with thermofor groupOther

    Ineffective heel warming will be applied to the newborns in the control group with a thermofor containing 28C warm water for 5 minutes before the heel blood collection procedure. During the procedure, the general condition of the newborn and the changes in his skin will be observed closely. Heel blood collection will be performed by following the standard procedure steps that are routinely applied in the service.

Study groups in NCT05228366
Study groupRoleWhat they receive
Heel warming with mild thermofor groupExperimentalHeel warming will be applied to the newborns in the ıntervention group 1 with a thermofor containing 34-37C warm water for 5 minutes before the heel blood collection procedure. During the procedure, the general condition of the newborn and the changes in his skin will be observed closely. Heel blood collection will be performed by following the standard procedure steps that are routinely applied in the service.
Receives: Other: Heel warming with mild thermofor group
Heel warming with hot thermofor groupExperimentalHeel warming will be applied to the newborns in the ıntervention group 2 with a thermofor containing 38-40C warm water for 5 minutes before the heel blood collection procedure. During the procedure, the general condition of the newborn and the changes in his skin will be observed closely. Heel blood collection will be performed by following the standard procedure steps that are routinely applied in the service.
Receives: Other: Heel warming with hot thermofor group
Ineffective heel warming with thermofor groupOtherIneffective heel warming will be applied to the newborns in the control group with a thermofor containing 28C warm water for 5 minutes before the heel blood collection procedure. During the procedure, the general condition of the newborn and the changes in his skin will be observed closely. Heel blood collection will be performed by following the standard procedure steps that are routinely applied in the service.
Receives: Other: Ineffective heel warming with thermofor group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prosedüre time measure

    The video recording will be monitored by independent evaluator who do not know the purpose of the study, and the processing time will be recorded.

    Measured: During the procedure

Secondary outcomes (1)
  1. Total crying time

    The video recording will be monitored by independent evaluator who do not know the purpose of the study, and the total crying time will be recorded.

    Measured: Up to 5 minutes after the heel stick

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Feb 2022
  2. Study start11 May 2022
  3. Primary completion18 Oct 2022
  4. Study completion18 Oct 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
3-armed randomized controlled trial
Masking
Single blind
Who is masked
Participant
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05228366
Sponsor's protocol ID
IspartaUASNursingCare2
Status last verified
Feb 2022
First submitted
12 Jan 2022
Last updated
14 Mar 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: N/O

Publications

  • Shu SH, Lee YL, Hayter M, Wang RH. Efficacy of swaddling and heel warming on pain response to heel stick in neonates: a randomised control trial. J Clin Nurs. 2014 Nov;23(21-22):3107-14. doi: 10.1111/jocn.12549. Epub 2014 Jan 30.

    PubMed 24476226

Questions about this trial

What is this clinical trial studying?

A study testing Heel warming with mild thermofor group, Heel warming with hot thermofor group and Ineffective heel warming with thermofor group in people with Nursing Caries, run by Isparta University of Applied Sciences at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prosedüre time measure (time frame: During the procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05228366, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Mar 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in